Journal
JOURNAL OF CRANIO-MAXILLOFACIAL SURGERY
Volume 32, Issue 6, Pages 365-369Publisher
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.jcms.2004.06.003
Keywords
bone morphogenetic protein-2; osteoinductive property; BrdII
Categories
Ask authors/readers for more resources
Introduction: Recombinant human bone morphogenetic protein-2 (rh-BMP2) has osteoinductive properties. The sequence of osteogenesis induced by rh-BMP2 in a rat calvarial bone defect model was evaluated histologically. Material and methods: Atelopeptide type I collagen was selected as the carrier matrix for rh-BMP2. This collagen was mixed with 50 mug of rh-BMP2 and treated by lyophilization to make a suitable form for filling bone defects. Thirty Wistar rats (male; 10 weeks old) underwent craniotomy resulting in a round bone defect with a diameter of 4 mm. Three weeks after the operation, the defect site was exposed to implant collagen with rh-BMP2 in the experimental group and collagen only in the control group. Three, 6 and 9 weeks after implantation, calvarial specimens were harvested and stained with haematoxylin/eosin. In addition, bromodeoxyuridine (BrdU) immunobistochemical staining was performed. Results: In the experimental group, marked ossification was found. In contrast, there was no tendency towards osteogenesis in the control group, 9 weeks after collagen implantation. In BrdU immunohistochemical staining, the number of BrdU-positive cells was significantly higher in the experimental group than in the control group, and was significantly higher at the periosteal site than at other sites at 3 and 6 weeks after implantation. Conclusions: rh-BMP2 exhibited osteoinductive properties, and markedly stimulated proliferation of periosteal cells. (C) 2004 European Association for Cranio-Maxillofaciat Surgery.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available